Tetralogy of fallot cardiac catheterization

Revision as of 16:17, 15 August 2011 by Priyamvada Singh (talk | contribs)
Jump to navigation Jump to search

Tetralogy of fallot Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Tetalogy of Fallot from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural history, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiography

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

ACC/AHA Guidelines for Evaluation and Follow-up


Tetralogy of fallot cardiac catheterization On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Tetralogy of fallot cardiac catheterization

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Tetralogy of fallot cardiac catheterization

CDC on Tetralogy of fallot cardiac catheterization

Tetralogy of fallot cardiac catheterization in the news

Blogs on Tetralogy of fallot cardiac catheterization

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Tetralogy of fallot cardiac catheterization

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Priyamvada Singh, M.B.B.S. [2], Keri Shafer, M.D. [3]; Atif Mohammad, M.D.; Assistant Editor-In-Chief: Kristin Feeney, B.S. [4]

Overview

Although this is an invasive method, it is possible to confirm the diagnosis and obtain additional anatomical and hemodynamic data, including the location and magnitude of right to left shunting, the level and severity of right ventricular outflow obstruction, the anatomical features of the right ventricular outflow tract and the main pulmonary artery and its branches, and the origin and course of the coronary arteries.

The(ACC/AHA) recommendations for interventional catheterization in patients with previously repaired Tetralogy of Fallot [1](DONOT EDIT)

Class I

1. Interventional catheterization in an ACHD center is indicated for patients with previously repaired tetralogy of Fallot with the following indications:

1. To eliminate residual native or palliative systemic–pulmonary artery shunts. (Level of Evidence: B)
2. To manage coronary artery disease. (Level of Evidence: B)

Class IIa

1. Interventional catheterization in an ACHD center is reasonable in patients with repaired tetralogy of Fallot to eliminate a residual ASD or VSD with a left-to-right shunt greater than 1.5:1 if it is in an appropriate anatomic location. (Level of Evidence: C)

The(ACC/AHA) recommendations for diagnostic and interventional catheterization for adults With Tetralogy of Fallot [1](DONOT EDIT)

Class I

1. Catheterization of adults with tetralogy of Fallot should be performed in regional centers with expertise in ACHD. (Level of Evidence: C) 2. Coronary artery delineation should be performed before any intervention for the right ventricular outflow tract (RVOT). (Level of Evidence: C)

Class IIb

1. In adults with repaired tetralogy of Fallot, catheterization may be considered to better define potentially treatable causes of otherwise unexplained left ventricle (LV) or right ventricle (RV) dysfunction, fluid retention, chest pain, or cyanosis. In these circumstances, transcatheter interventions may include:

1. Elimination of residual shunts or aortopulmonary collateral vessels. (Level of Evidence: C)
2. Dilation (with or without stent implantation) of RVOT obstruction. (Level of Evidence: B)
3. Elimination of additional muscular or patch margin ventricular septal defect (VSD). (Level of Evidence: C)
4. Elimination of residual atrial septal defect (ASD). (Level of Evidence: B)


For ACC/AHA Level of evidence and classes click:ACC AHA Guidelines Classification Scheme

References

  1. 1.0 1.1 Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA; et al. (2008). "ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". J Am Coll Cardiol. 52 (23): e1–121. doi:10.1016/j.jacc.2008.10.001. PMID 19038677.

See also

External links

de:Fallot-Tetralogie it:Tetralogia di Fallot nl:Tetralogie van Fallot nn:Fallots tetrade uk:Тетрада Фалло


Template:WikiDoc Sources